Influenza Vaccine Elicited Immune Response in Immunocompromised Patients

Clinical trial NCT06738082 · COMPLETED

Trial details

NCT number: NCT06738082
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Study type: OBSERVATIONAL

Influenza Vaccine Immunocompromised Patients

Start date: 2024-10-15
Primary completion: 2025-01-31
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.